Selecta Biosciences’ Post

View organization page for Selecta Biosciences, graphic

3,628 followers

We are excited to announce the merger of Selecta Biosciences and Cartesian Therapeutics to create a fully integrated, publicly traded company pioneering RNA cell therapy for the treatment of autoimmune disease. Please follow us on our new page Cartesian Therapeutics to continue to follow the story and receive updates on our progress. For more information on the merge, click here: https://lnkd.in/eMqMPj3M

To view or add a comment, sign in

Explore topics